Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.

Zhang, Ye

Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine. [electronic resource] - European journal of gastroenterology & hepatology Jul 2013 - 814-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1473-5687

10.1097/MEG.0b013e32835ee516 doi


Adenine--adverse effects
Antiviral Agents--adverse effects
Biomarkers--blood
Chi-Square Distribution
DNA, Viral--blood
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Genotype
Hepatitis B e Antigens--blood
Hepatitis B virus--drug effects
Hepatitis B, Chronic--diagnosis
Humans
Organophosphonates--adverse effects
Phenotype
Telbivudine
Thymidine--adverse effects
Time Factors
Treatment Outcome
Viral Load
Virus Replication--drug effects